Sentence examples for a commonly used endpoint from inspiring English sources

The BPI "worst pain" item is a commonly used endpoint for measuring pain and has been included in a number of drug labels in the US and Europe [15].

Cause-specific mortality is a commonly used endpoint of clinical trials or prospective studies.

Successful weight loss maintenance has been defined in terms of weight status 1-year post-weight loss intervention [ 19], with a maintained weight loss of ≥5% of initial weight as a commonly used endpoint to describe weight loss success [ 19].

Although 3-year disease-free survival (3-years-DFS) using CT imaging is a commonly used endpoint in adjuvant setting, 18 month laparoscopy is more appropriate in this trial because of the restricted sensitivity of imaging modalities to detect PC at an early stage.

In clinical trials designed to improve pulmonary and respiratory outcomes for preterm neonates, the most commonly used endpoint has been BPD.

As mentioned, SVR is the most commonly used endpoint in clinical trials in hepatitis C because the use of incidence of HCC or liver-related mortality as an endpoint is impractical within the context of a clinical trial.

This information was then used as a basis to address whether the commonly used endpoints would be appropriate to assess the medical value of therapies with the potential for long-term survival and how/whether these endpoints may support the notion of a "cure" in the way normally understood.

Hi everyone, The core functionality and commonly used endpoints of GeoAPI.com have already been migrated to the Twitter API, and many are in use on twitter.com today.

Therefore, time-to-event and binary (as in absence/presence of partial or complete response) are the most commonly used endpoints in oncologic drug development [ 37, 46].

Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) program to develop standardized definitions of commonly used endpoints, enabling appropriate comparisons of future trials is currently ongoing 30.

The performance of the 20 gene-signature as well as each of the individual gene was measured using AUROCC based on commonly used endpoints: time to distant metastasis(TDM) at 5 years and 10 years.